Internal Medicine, Gastroenterology · Austin, TX
NPI
1477651982
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4310 James Casey St, Ste 4a
Austin, TX, 78745
Phone (512) 448-4588
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
977 services
Medicare patients, 2024
586
Average age 73
Drug cost, 2024
$1.2M
2,282 prescriptions
Company payments, 2025
$2,852
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel S Emmett was code 99213 (office e&m - established), 202 times for 183 patients. In total Daniel S Emmett billed 977 services in 30 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 202 | 183 | $58.48 | $12K |
| 45380 Lower GI Endoscopy - Other | Facility | 148 | 148 | $116.25 | $17K |
| 99214 Office E&M - Established | Office | 135 | 126 | $88.10 | $12K |
| 43239 Upper GI Endoscopy | Facility | 113 | 112 | $65.90 | $7,447 |
| 45385 Colonoscopy - Lesion Removal | Facility | 82 | 82 | $192.41 | $16K |
| 99203 Office E&M - New | Office | 79 | 79 | $66.84 | $5,281 |
| 99204 Office E&M - New | Office | 46 | 46 | $114.86 | $5,283 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 32 | 32 | $171.18 | $5,478 |
| 43248 Upper GI Endoscopy | Facility | 24 | 24 | $103.42 | $2,482 |
| 91110 Standard X-ray | Office | 23 | 23 | $580.05 | $13K |
| 99212 Office E&M - Established | Office | 16 | 16 | $43.32 | $693 |
| 91200 Standard X-ray | Office | 12 | 12 | $21.52 | $258 |
| 45378 Lower GI Endoscopy - Other | Facility | 12 | 12 | $119.70 | $1,436 |
By year: 2022 $104K for 1,104 services; 2023 $96K for 997 services; 2024 $105K for 977 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel S Emmett prescribed most often to Medicare patients was Pantoprazole Sodium, with 655 prescriptions and refills. In total Daniel S Emmett wrote 2,282 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 655 | 1,820 | 244 | $7,363 |
| Omeprazole Generic | 285 | 759 | 102 | $4,410 |
| Dicyclomine Hcl Generic | 176 | 256 | 58 | $3,288 |
| Esomeprazole Magnesium Generic | 135 | 360 | 42 | $4,618 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 117 | 117 | 111 | $20K |
| Linzess Linaclotide | 86 | 146 | 21 | $74K |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 67 | 67 | 66 | $9,047 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 55 | 55 | 54 | $3,233 |
| Ondansetron Odt Ondansetron | 42 | 42 | 15 | $613 |
| Xifaxan Rifaximin | 42 | 46 | 19 | $130K |
| Metoclopramide Hcl Generic | 39 | 65 | Under 11 | $500 |
| Famotidine Generic | 38 | 93 | 15 | $603 |
| Dexlansoprazole Dr Dexlansoprazole | 37 | 101 | 13 | $15K |
| Dextrose 5%-0.45% Nacl Dextrose 5 %-0.45 % Sod Chlord | 36 | 36 | Under 11 | $1,559 |
| Mesalamine Generic | 32 | 70 | Under 11 | $14K |
Brand drugs: - claims; generic drugs: 1,738 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel S Emmett $2,852 ($2,852 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $897.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 46 | $897 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 29 | $313 |
| Celltrion USA Inc. 068270.KS | 17 | $211 |
| Pfizer Inc. PFE | 20 | $205 |
| Ardelyx, Inc. ARDX | 9 | $158 |
| Medtronic, Inc. MDT | 2 | $152 |
| Genzyme Corporation SNY | 4 | $138 |
| QOL Medical, LLC | 4 | $136 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 5 | $133 |
| Madrigal Pharmaceuticals MDGL | 4 | $96.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.